Company Filing History:
Years Active: 2018
Title: Inventor Yonghwan Jin: A Pioneer in Genetic Modification
Introduction
Yonghwan Jin, a distinguished inventor based in King of Prussia, PA, has made notable contributions in the field of genetic engineering. His innovative work has led to the development of advanced genetically modified host cells, particularly related to yeast cells.
Latest Patents
Yonghwan Jin holds one patent titled "Host cells and methods of use." This groundbreaking invention pertains to genetically modified host cells that incorporate at least one isolated polynucleotide encoding a Killer Expression protease (Kex2p) or its functional variants. The patent further encompasses genetically modified host cells with isolated polynucleotides encoding a Protein Disulfide-Isomerase (Pdi1) and an Endoplasmic Reticulum Oxidoreductin (Ero1), all maintaining important functional activities critical for biotechnological applications.
Career Highlights
Yonghwan Jin is currently employed at GlaxoSmithKline LLC, where he continues to advance his research and innovation in genetic modifications. His work significantly contributes to the pharmaceutical industry, enhancing potential therapeutic applications and bioprocess efficiencies.
Collaborations
In his professional journey, Yonghwan collaborates with esteemed colleagues, one of whom is Yuan Zhu. This collaboration fosters an environment of innovation, leading to new advancements in their respective fields and enhancing the scope of their research.
Conclusion
Yonghwan Jin's contributions to the field of genetic engineering exemplify the essence of innovation. His work not only paves the way for future advancements in biotechnology but also underscores the importance of collaboration among scientists and inventors. Through his dedication and expertise, Yonghwan Jin continues to inspire future generations of innovators.